The Manufacture of GMP-Grade Bone Marrow Stromal Cells with Validated In Vivo Bone-Forming Potential in an Orthopedic Clinical Center in Brazil

Table 5

Immunophenotypic characterization of the lots of BMSCs that were produced.

	%CD73	%CD90	%CD105	%CD146	%CD73/CD90/CD105/CD146	%CD11b	%CD14	%CD34	%CD45
BMSC 05	99.8	99.8	62.3	99.7	70.2	0.59	2.20	1.34	3.21
BMSC 06	100	100	82.3	99.9	82.3	0.86	1.85	0.56	2.85
BMSC 07	100	100	83.3	99.1	73.4	2.38	0.69	0.16	3.32
BMSC 08	97.6	97.6	100	100	95	0.25	0.11	0.45	0.98
BMSC 09	100	98.1	66.4	98.3	50.1	0.69	1.24	0.55	2.39
BMSC 10	92.7	99.6	99.4	99.3	98.8	0.62	0.18	0.22	2.85
BMSC 11	99.7	97.1	95.8	88.4	62.9	1.35	1.14	2.17	2.67
BMSC 12	99.9	99.4	75.2	100	86.1	1.03	0.11	0.11	1.26
BMSC 13	100	100	89.2	100	72.2	3.56	0.19	0.80	4.18
BMSC 14	99.7	98.9	98.3	99.1	82.9	0.12	0.08	1.09	0.26